Evidence map

TrialXenobiotica; the fate of foreign compounds in biological systems2014

Absorption, metabolism and excretion of [14C]gemigliptin, a novel dipeptidyl peptidase 4 inhibitor, in humans.

Namtae Kim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

11 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 24304170